| Security Name | Asset Type |
Shares or Principal Amount |
Market Value |
Percent of Net Assets |
|---|---|---|---|---|
| Capital Group Central Cash Fund | Short Term | 8,305,418 | $830,375,668.00 | 7.26% |
| U.S. Treasury 5.00% 5/15/2056 | Fixed Income | 203,935,600 | $185,621,235.00 | 1.62% |
| U.S. Treasury 5.125% 8/15/2046 | Fixed Income | 147,583,000 | $138,059,285.00 | 1.21% |
| U.S. Treasury 5.00% 9/30/2031 | Fixed Income | 133,235,900 | $132,814,328.00 | 1.16% |
| Goldman Sachs Group, Inc. 4.939% 10/21/2036 (USD-SOFR + 1.33% on 10/21/2035) | Fixed Income | 93,319,000 | $84,694,085.00 | 0.74% |
| Goldman Sachs Group, Inc. 5.425% 6/3/2037 (USD-SOFR + 1.31% on 6/3/2036) | Fixed Income | 84,459,000 | $78,990,026.00 | 0.69% |
| Abbott Laboratories 4.65% 3/15/2036 | Fixed Income | 84,796,000 | $77,304,867.00 | 0.68% |
| Bristol-Myers Squibb Co. 5.20% 2/22/2034 | Fixed Income | 81,008,000 | $78,242,630.00 | 0.68% |
| Chubb INA Holdings, LLC 5.00% 3/15/2034 | Fixed Income | 77,669,000 | $73,361,710.00 | 0.64% |
| PacifiCorp 5.80% 4/15/2036 | Fixed Income | 74,448,000 | $71,768,691.00 | 0.63% |
| Morgan Stanley 4.892% 10/22/2036 (USD-SOFR + 1.314% on 10/22/2035) | Fixed Income | 77,593,000 | $70,328,123.00 | 0.61% |
| U.S. Treasury 4.375% 9/15/2029 | Fixed Income | 70,232,500 | $69,072,017.00 | 0.6% |
| Bank of America Corp. 2.299% 7/21/2032 (USD-SOFR + 1.22% on 7/21/2031) | Fixed Income | 77,271,000 | $65,839,992.00 | 0.58% |
| U.S. Treasury 4.75% 9/30/2028 | Fixed Income | 65,626,000 | $65,472,189.00 | 0.57% |
| AbbVie, Inc. 5.05% 3/15/2034 | Fixed Income | 66,997,000 | $64,018,514.00 | 0.56% |